EndoChoice (GI) Tops Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
EndoChoice Announces Fourth Quarter and Full Year 2015 Financial Results and Provides Guidance for 2016
March 3, 2016 7:00 AM ESTALPHARETTA, Ga., March 3, 2016 /PRNewswire/ --Â EndoChoice Holdings, Inc. (NYSE:Â GI)Â announced today financial results for the fourth quarter and full year 2015.
2015 Highlights
Revenue of $72.3 million, up 18% year-over-year (20% in constant currency) Installed base of Fuse® reaches 123 systems; end user systems increased 116% in 2015. Pathology revenue up 10% year-over-year driven by 20% specimen growth and 18% customer growth International revenue up 11% year-over-year (33% in constant currency) Launched two new Single Use Products in 2015; four launches planned for 2016Mark Gilreath, Founder and Chief Executive Officer of EndoChoice, said, "In 2015 we made... More
